Clinical benefits of prucalopride in colon capsule endoscopy: A Real-World comparative analysis
Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S862-S863
DOI: 10.1055/s-0046-1822367 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von B Németh und 12 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
Colon capsule endoscopy (CCE) is a noninvasive alternative for colorectal evaluation; however, its widespread adoption has been limited by historically suboptimal completion rates and inadequate colonic cleanliness compared with conventional colonoscopy. Prucalopride, a selective 5-HT4 agonist, may improve gastrointestinal motility and enhance CCE performance, but real-world data are limited.
Methods
A prospective, cohort analysis was performed on 500 CCE examinations. Asymptomatic, FIT negative patients (aged between 40 and 60 years) were enrolled and divided into two groups: those who did not receive prucalopride and/or fleet enema (n=250) and those who received 2 mg prucalopride immediately after gastric imaging (n=250). In this group if colonic transit was already prolonged, patients (who consented) received an on-demand rectal sodium phosphate enema as a rescue booster. Gastric, small bowel, colonic and total transit times were compared using Welch’s t-test. Completion rates (defined as excretion or visualization of the hemorrhoidal plexus before battery depletion) were compared using chi-square and Fisher’s exact tests. Polyp detection rates and CC-CLEAR colonic cleanliness scores were also analyzed.
Results
Prucalopride and enema booster administration significantly reduced small bowel transit time (mean 99.7 vs. 54.6 min, p
Zitieren
APA
Németh, B., Finta, A., Bélafi, D., Novák, P., Göbl, J., Szombath, R., Tupcsia, F., Maróti, Z., Sziklási, T., Tőgl, K., Szalai, M., Katona, M., & Madácsy, L. (2026). Clinical benefits of prucalopride in colon capsule endoscopy: A Real-World comparative analysis. Endoscopy, 58(S 03 S 03), S862-S863. https://doi.org/10.1055/s-0046-1822367
Vancouver
Németh B, Finta A, Bélafi D, Novák P, Göbl J, Szombath R, et al. Clinical benefits of prucalopride in colon capsule endoscopy: A Real-World comparative analysis. Endoscopy. 2026;58(S 03 S 03):S862-S863. doi:10.1055/s-0046-1822367
BibTeX
@article{Nmeth2026,
author = {Németh, B and Finta, A and Bélafi, D and Novák, P and Göbl, J and Szombath, R and Tupcsia, F and Maróti, Z and Sziklási, T and Tőgl, K and Szalai, M and Katona, M and Madácsy, L},
title = {Clinical benefits of prucalopride in colon capsule endoscopy: A Real-World comparative analysis},
journal = {Endoscopy},
year = {2026},
volume = {58},
number = {S 03 S 03},
pages = {S862--S863},
doi = {10.1055/s-0046-1822367}
}
EUVIMED